The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
WINLEVI (Sun Pharma ANZ Pty Ltd)
Product name
WINLEVI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
194 (255 working days)
Active ingredients
clascoterone
Registration type
NCE/NBE
Indication
WINLEVI (clascoterone) cream is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.